Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kaspar Draaisma

Showing results (1-10 of 14) with videos related to

Pageof 2
Sort By:
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 18, 2016
Systematic Review on Surgical Outcomes and Hearing Preservation for Cochlear Implantation in Children and AdultsHanneke Bruijnzeel, Kaspar Draaisma, Roderick van Grootel, et al.
Cancers|August 7, 2021
Glioblastomas within the Subventricular Zone Are Region-Specific Enriched for Mesenchymal Transition Markers: An Intratumoral Gene Expression AnalysisDiana J Z Dalemans, Sharon Berendsen, Kaspar Draaisma, et al.
Scientific Reports|October 12, 2019
Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigensBas Weenink, Kaspar Draaisma, Han Z Ooi, et al.
Acta Neuropathologica Communications|December 25, 2015
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patientsKaspar Draaisma, Maarten M J Wijnenga, Bas Weenink, et al.
Neuro-Oncology Advances|January 20, 2022
Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomasWesley S van de Geer, Youri Hoogstrate, Kaspar Draaisma, et al.
World Neurosurgery|March 19, 2019
Routine Blood Tests Do Not Predict Survival in Patients with Glioblastoma-Multivariable Analysis of 497 PatientsSybren L N Maas, Kaspar Draaisma, Tom J Snijders, et al.
Neuro-Oncology|January 4, 2026
Epigenetic evolution of IDHwt glioblastomasBo Deng, Rania Head, Kaspar Draaisma, et al.
Acta Neurochirurgica|January 8, 2022
International practice variation in perioperative laboratory testing in glioblastoma patients-a retrospective cohort studyJoeky T Senders, Sybren L N Maas, Kaspar Draaisma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2019
Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 StudyKaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialKaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, et al.
Pageof 2

Showing results (1-10 of 14) with videos related to

Sort By:
Pageof 2
Otolaryngology--Head and Neck Surgery : Official Journal of American Academy of Otolaryngology-Head and Neck Surgery|February 18, 2016
Systematic Review on Surgical Outcomes and Hearing Preservation for Cochlear Implantation in Children and AdultsHanneke Bruijnzeel, Kaspar Draaisma, Roderick van Grootel, et al.
Cancers|August 7, 2021
Glioblastomas within the Subventricular Zone Are Region-Specific Enriched for Mesenchymal Transition Markers: An Intratumoral Gene Expression AnalysisDiana J Z Dalemans, Sharon Berendsen, Kaspar Draaisma, et al.
Scientific Reports|October 12, 2019
Low-grade glioma harbors few CD8 T cells, which is accompanied by decreased expression of chemo-attractants, not immunogenic antigensBas Weenink, Kaspar Draaisma, Han Z Ooi, et al.
Acta Neuropathologica Communications|December 25, 2015
PI3 kinase mutations and mutational load as poor prognostic markers in diffuse glioma patientsKaspar Draaisma, Maarten M J Wijnenga, Bas Weenink, et al.
Neuro-Oncology Advances|January 20, 2022
Landscape of driver gene events, biomarkers, and druggable targets identified by whole-genome sequencing of glioblastomasWesley S van de Geer, Youri Hoogstrate, Kaspar Draaisma, et al.
World Neurosurgery|March 19, 2019
Routine Blood Tests Do Not Predict Survival in Patients with Glioblastoma-Multivariable Analysis of 497 PatientsSybren L N Maas, Kaspar Draaisma, Tom J Snijders, et al.
Neuro-Oncology|January 4, 2026
Epigenetic evolution of IDHwt glioblastomasBo Deng, Rania Head, Kaspar Draaisma, et al.
Acta Neurochirurgica|January 8, 2022
International practice variation in perioperative laboratory testing in glioblastoma patients-a retrospective cohort studyJoeky T Senders, Sybren L N Maas, Kaspar Draaisma, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|November 20, 2019
Molecular Evolution of <i>IDH</i> Wild-Type Glioblastomas Treated With Standard of Care Affects Survival and Design of Precision Medicine Trials: A Report From the EORTC 1542 StudyKaspar Draaisma, Aikaterini Chatzipli, Martin Taphoorn, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 16, 2022
Prognostic Significance of DNA Methylation Profiles at MRI Enhancing Tumor Recurrence: a Report from the EORTC 26091 TAVAREC TrialKaspar Draaisma, C Mircea S Tesileanu, Iris de Heer, et al.
Pageof 2